111, Inc. YI

Latest FY: 2025 Healthcare Medical Distribution
Market Price $3.63
Market Cap $31.93M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-9.0% YoY
$1.80B
3-Yr CAGR: -2.9%
Net Income ↓-2.5% YoY
-$66.39M
Net Margin: -3.7%
Free Cash Flow ↓-51.7% YoY
$16.40M
FCF Yield: 51.36%
EPS (Diluted) 0.0% YoY
$-0.05
Basic: $-0.05
Return on Equity Efficiency
N/A
ROA: -3.0%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (YI)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $873.8M $266.0M $-418.0M $-388.6M $-388.8M
FY 2017 $959.5M +9.8% $80.5M $-249.3M +40.3% $-204.4M $-211.2M +45.7%
FY 2018 $259.8M -72.9% $88.5M $-382.0M -53.2% $-49.9M $-52.0M +75.4%
FY 2019 $567.7M +118.5% $142.8M $-71.8M +81.2% $-73.6M $-76.5M -47.1%
FY 2020 $1,257.2M +121.5% $365.8M $-70.0M +2.5% $-17.9M $-21.8M +71.5%
FY 2021 $1,949.9M +55.1% $621.1M $-105.1M -50.2% $-0.63 $-108.1M $-117.9M -440.7%
FY 2022 $1,959.7M +0.5% $840.0M $-416.9M -296.6% $-0.36 +42.9% $-3.4M $-7.9M +93.3%
FY 2023 $2,105.4M +7.4% $849.0M $-392.7M +5.8% $-0.33 +8.3% $-63.0M $-64.4M -711.4%
FY 2024 $1,973.0M -6.3% $829.2M $-64.7M +83.5% $-0.05 +84.8% $36.0M $34.0M +152.7%
FY 2025 $1,795.5M -9.0% $723.4M $-66.4M -2.5% $-0.05 0.0% $17.0M $16.4M -51.7%
$

Valuation

Market Price $3.63
Market Cap $31.93M
Enterprise Value $225.54M
P/E Ratio N/A
P/B Ratio N/A
FCF Yield 51.36%
Dividend Yield N/A
Shares Outstanding 8,796,964
%

Profitability & Margins

Gross Margin 40.29%
Operating Margin -0.02%
Net Margin -3.70%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) -3.02%
Asset Turnover 0.82x
Revenue 3-Yr CAGR -2.88%
🛡️

Financial Health & Liquidity

Current Ratio 0.58
Cash Ratio 1.51
Debt / Equity -2.656
Debt / Assets 0.121
Cash & Equivalents $73.07M
Total Debt $266.68M
Book Value / Share $-11.42
💧

Cash Flow Efficiency

Operating Cash Flow $17.04M
Capital Expenditures (CapEx) $636.00K
Free Cash Flow $16.40M
OCF / Revenue 0.95%
FCF / Revenue 0.91%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.05
EPS (Basic) $-0.05
Dividends / Share N/A
Book Value / Share $-11.42
EPS YoY Growth 0.00%
🏛️

Balance Sheet (FY 2025)

Total Assets $2.20B
Total Liabilities $1.99B
Stockholders' Equity -$100.42M
Current Assets $28.14M
Current Liabilities $48.25M